Consistent with our previous observations, IFNγR2- and Jak1-mutant B16F10 tumors also exhibited slower tumor growth, although the difference in growth rate was less pronounced presumably due to decreased antigenicity (Supplementary Fig. 3f). This evidence concerns the gene JAK1 and neoplasm.